Radiation InjuriesRadiation DosageAntineoplastic AgentsRadiation, IonizingDose-Response Relationship, RadiationRadiation ToleranceRadiotherapyRadiotherapy DosageRadiationCell Line, TumorNeoplasmsCombined Modality TherapyDrug Screening Assays, AntitumorRadiation ProtectionRadiation OncologyRadiotherapy, ConformalRadiation MonitoringRadiotherapy, Intensity-ModulatedDoxorubicinApoptosisDose FractionationRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation PneumonitisCisplatinCell SurvivalDrug Resistance, NeoplasmBrachytherapyRadiation-Sensitizing AgentsAntineoplastic Agents, PhytogenicDNA DamageGamma RaysRadiometryNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalAntibiotics, AntineoplasticTumor Cells, CulturedRadiosurgeryDrug Delivery SystemsTreatment OutcomeBrain NeoplasmsBreast NeoplasmsCosmic RadiationXenograft Model Antitumor AssaysMice, NudeCell ProliferationRadiotherapy, Computer-AssistedTime FactorsDrug CarriersEtoposideCranial IrradiationAntineoplastic Combined Chemotherapy ProtocolsPaclitaxelUltraviolet RaysHead and Neck NeoplasmsParticle AcceleratorsNeoplasm Recurrence, LocalRadiotherapy, Image-GuidedRadiation-Protective AgentsCell CycleBackground RadiationFluorouracilEllipticinesDose-Response Relationship, DrugSignal TransductionRadiodermatitisCamptothecinProstatic NeoplasmsRadiotherapy, High-EnergyLung NeoplasmsAdenocarcinomaCarcinoma, Squamous CellDNA RepairNeoplasm StagingTumor Suppressor Protein p53Organs at RiskInhibitory Concentration 50Tumor BurdenDrug Resistance, MultipleMolecular StructureP-GlycoproteinRadiation EffectsCobalt RadioisotopesEnzyme InhibitorsSurvival AnalysisRetrospective StudiesDrug DesignDrug SynergismChemoradiotherapyGene Expression Regulation, NeoplasticAntineoplastic Agents, AlkylatingModels, BiologicalAntimetabolites, AntineoplasticRadiobiologyCell LineDisease-Free SurvivalX-RaysGlioblastomaTomography, X-Ray ComputedProdrugs